| Source | Code | Name | Case count | Share of cases (%) |
|---|---|---|---|---|
| REIMB | REIMB_KELA(317)_ICD10(L20) | Topical pimecrolimus and tacrolimus, Atopic dermatitis | 1912 | |
| REIMB | REIMB_KELA(317)_ICD10(L200) | Topical pimecrolimus and tacrolimus, Besnier's prurigo | 1028 | |
| REIMB | REIMB_KELA(134)_ICD10(L400) | General erythroderma, Psoriasis vulgaris | 207 | |
| REIMB | REIMB_KELA(134)_ICD10(L26) | General erythroderma, Exfoliative dermatitis | 93 | |
| REIMB | REIMB_KELA(134)_ICD9(NA) | General erythroderma, Name not found | 72 | |
| REIMB | REIMB_KELA(395)_ICD10(L20) | Dupilumab, Atopic dermatitis | 59 | |
| REIMB | REIMB_KELA(134)_ICD10(L20) | General erythroderma, Atopic dermatitis | 53 | |
| REIMB | REIMB_KELA(395)_ICD10(L200) | Dupilumab, Besnier's prurigo | 45 | |
| REIMB | REIMB_KELA(134)_ICD8(NA) | General erythroderma, Name not found | 24 | |
| REIMB | REIMB_KELA(395)_ICD10(J45) | Dupilumab, Asthma | 21 | |
| REIMB | REIMB_KELA(134)_ICD10(L200) | General erythroderma, Besnier's prurigo | 16 | |
| REIMB | REIMB_KELA(317)_ICD10(L209) | Topical pimecrolimus and tacrolimus, Atopic dermatitis, unspecified | 15 | |
| REIMB | REIMB_KELA(134)_ICD9(6961A) | General erythroderma, Psoriasis and similar disorders, Other psoriasis | 14 | |
| REIMB | REIMB_KELA(134)_ICD10(NA) | General erythroderma, Name not found | 9 | |
| REIMB | REIMB_KELA(134)_ICD10(L53) | General erythroderma, Other erythematous conditions | 6 | |
| REIMB | REIMB_KELA(395)_ICD10(J451) | Dupilumab, Nonallergic asthma | 6 | |
| REIMB | REIMB_KELA(395)_ICD10(J450) | Dupilumab, Predominantly allergic asthma | 5 |